Abstract:Various cancer therapies have advanced remarkably over the past decade. Unlike the direct therapeutic targeting of tumor cells, cancer immunotherapy is a new strategy that boosts the host's immune system to detect specific cancer cells for efficient elimination. Unfortunately, the efficacy of these treatments has been limited to a fraction of patients within a subset of tumor types, and further studies are still needed to clarify these mechanisms and develop novel approaches to improve the efficacy of cancer immunotherapy. Emerging data suggest that the innate immune system also plays a key role in tumor immunosurveillance and generation of antitumor immune responses. Nanoparticles incorporating immunomodulatory agents can activate immune cells and modulate the tumor microenvironment to enhance antitumor immunity. Such nanoparticle-based cancer immunotherapies have received considerable attention and have been extensively studied in recent years. In this review, we will discuss the anticancer activities of nanoparticles designed to target innate immune pathways, including Toll-like receptor, nucleotide-binding oligomerization domain-like receptor, and retinoic acid-inducible gene-I-like receptor pathways, as well as DNA sensing pathways. In addition, nanoparticles that target key innate immune cell types, such as macrophages, myeloid-derived suppressor cells, dendritic cells, natural killer cells, and neutrophils, also will be investigated. In summary, although further research and clinical studies are still needed to solve the safety concerns and improve the efficacy of nanoplatform-based cancer immunotherapy, the recent studies presented in this review prove that nanoparticle-incorporated cancer immunotherapy is a highly promising treatment for cancer patients.

Cationic nanoparticles-based approaches for immune tolerance induction in vivo

Nanoparticle-Based Drug Delivery Systems for Induction of Tolerance and Treatment of Autoimmune Diseases

Nanomaterials for antigen-specific immune tolerance therapy

Advances in dendritic cell targeting nano-delivery systems for induction of immune tolerance

Nanoparticle-assisted Targeting Delivery Technologies for Preventing Organ Rejection

Tolerogenic Nano-/Microparticle Vaccines for Immunotherapy.

Strategies to Achieve Immune Tolerance in Allogeneic Solid Organ Transplantation.

Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance

Progress in Nanoparticle-Based Regulation of Immune Cells.

Application of nanotechnology in circumventing immunotolerance.

Targeting Lymphoid Tissues to Promote Immune Tolerance

Prospects of the Use of Cell Therapy to Induce Immune Tolerance

Nanoparticle-based T cell immunoimaging and immunomodulatory for diagnosing and treating transplant rejection

Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance

New strategies in immune tolerance induction

Bioconjugate Strategies for the Induction of Antigen-Specific Tolerance in Autoimmune Diseases

Antigen‐specific Mrna Lipid Nanoparticle Platforms for the Prevention and Treatment of Allergy and Autoimmune Diseases

Nanoparticles loaded with IL-2 and TGF-β promote transplantation tolerance to alloantigen

Polymer Nanotherapeutics to Correct Autoimmunity

Targeting the Innate Immune System with Nanoparticles for Cancer Immunotherapy

Negative Vaccination Strategies for Promotion of Transplant Tolerance